ScreenerHero
IQVIQVIA Holdings Inc
NYSE · US · Healthcare · Diagnostics & Research · iqvia.com
256.35USD+2.83%Mkt Cap: 41.03B $P/E: 31.00

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates …

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DAP
Danaher Corporation
$142.58BUSDP/E 38.5
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group AG
$47.21BUSDP/E 38.3
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILU
Illumina, Inc.
$30.40BUSDP/E 40.4
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8

Key Statistics

Company
Market Cap41.03B $
Enterprise Value56.45B $
Revenue (TTM)16.98B $
Gross Profit5.43B $
Net Income (TTM)1.36B $
Revenue/Share100.70 USD
Last Price256.35 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees94.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS46266C1053
Valuation
P/E (Trailing)31.00
P/E (Forward)17.73
PEG1.02
EV/EBITDA18.52
EV/Revenue3.32
P/S2.48
P/B6.83
EPS (TTM)8.27
EPS (Forward)14.44
52W Range
154.50100% of range251.35
52W High251.35 USD
52W Low154.50 USD
Profitability
Gross Margin33.29%
Oper. Margin13.03%
EBITDA Margin17.95%
Profit Margin8.34%
ROE20.91%
ROA4.54%
Growth
Revenue Growth8.70%
Earnings Growth-0.60%
Cash Flow & Leverage
Operating CF2.65B $
CapEx (TTM)603.00M $
FCF Margin12.66%
FCF Yield5.24%
Net Debt14.17B $
Net Debt/EBITDA4.65
Balance Sheet
Debt/Equity2.45
Current Ratio0.71
Quick Ratio0.62
Book Value/Sh37.49 USD
Cash/Share12.64 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)275.17 USD
Upside (mean)+7.3%
Target Range240.00 USD – 300.00 USD
$240.00+7.3% to mean$300.00
# Analysts18
Ownership
Shares Out.164.60M
Float156.25M
Insiders1.09%
Institutions103.40%
Short Interest
Short Ratio3.1d
Short % Float3.22%
Short % Out.2.77%
Shares Short4.56M
Short (prev mo.)4.98M
Technical
SMA 50211.41 (+21.3%)
SMA 200199.29 (+28.6%)
Beta1.18
S&P 52W Chg18.16%
Avg Vol (30d)1.12M
Avg Vol (10d)1.14M
Technical Indicators
RSI (14)67.8
MACD10.2031
MACD Signal10.4987
MACD Hist.-0.2955
BB Upper261.72 USD
BB Middle232.80 USD
BB Lower203.89 USD
BB Width24.84%
ATR (14)8.062 USD
Vol Ratio (20d)0.74x